MARKET

LNTH

LNTH

Lantheus Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.53
+0.07
+0.33%
After Hours: 21.53 0 0.00% 17:26 11/11 EST
OPEN
21.43
PREV CLOSE
21.46
HIGH
21.80
LOW
21.30
VOLUME
276.65K
TURNOVER
--
52 WEEK HIGH
29.80
52 WEEK LOW
13.82
MARKET CAP
845.01M
P/E (TTM)
24.87
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of LNTH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

LNTH News

  • Lantheus Releases Comprehensive Strategic Plan for Progenics
  • Business Wire.4d ago
  • Progenics stiff-arms activist investor opposed to Lantheus merger; shares up 5%
  • Seeking Alpha - Article.11/01 17:26
  • Edited Transcript of LNTH earnings conference call or presentation 31-Oct-19 12:00pm GMT
  • Thomson Reuters StreetEvents.11/01 06:14
  • Lantheus Holding Inc. (LNTH) CEO Mary Anne Heino on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/01 03:12

More

Industry

Medical Equipment, Supplies & Distribution
-0.15%
Healthcare Equipment & Supplies
-0.25%

Hot Stocks

Name
Price
%Change

About LNTH

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.
More

Webull offers Lantheus Holdings Inc (LNTH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.